Anzeige
Mehr »
Samstag, 29.11.2025 - Börsentäglich über 12.000 News
Internationale Expansion geplant: Medizintechnik aus dem Weltraum!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 897961 | ISIN: US8064071025 | Ticker-Symbol: HS2
Tradegate
26.11.25 | 20:20
64,98 Euro
+1,09 % +0,70
Branche
Gesundheitswesen
Aktienmarkt
S&P 500
1-Jahres-Chart
HENRY SCHEIN INC Chart 1 Jahr
5-Tage-Chart
HENRY SCHEIN INC 5-Tage-Chart
RealtimeGeldBriefZeit
63,9464,6028.11.
64,1864,3628.11.

Aktuelle News zur HENRY SCHEIN Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiBiomerica, Inc.: Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS2
12.11.Henry Schein auf der Stifel Healthcare Conference 2025: Strategische Initiativen und Wachstum4
04.11.HENRY SCHEIN INC - 10-Q, Quarterly Report9
04.11.Henry Schein signals over $200M operating income improvement opportunity as BOLD+1 and KKR partnership advance6
04.11.Henry Schein rises after lifting 2025 guidance4
04.11.Henry Schein Allows KKR To Buy Up To 19.9% Of Stake, Lifts Annual Outlook; Stock Up Over 8%350MELVILLE (dpa-AFX) - Henry Schein, Inc. (HSIC), a distributor of health care products and services, said on Tuesday that its Board has approved an amendment to the strategic partnership agreement...
► Artikel lesen
04.11.Henry Schein Inc. Q3 Profit Increases, Beats Estimates243MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) revealed a profit for its third quarter that Increased from the same period last year and beat the Street estimates.The company's bottom line came...
► Artikel lesen
HENRY SCHEIN Aktie jetzt für 0€ handeln
04.11.Henry Schein beats top-line and bottom-line estimates; raises FY25 outlook3
04.11.HENRY SCHEIN INC - 8-K, Current Report3
03.11.Henry Schein Q3 2025 Earnings Preview13
03.11.Henry Schein One partners with AWS to develop AI dental solutions3
03.11.Henry Schein, AWS partner on AI-powered dentistry2
23.10.Here's How Henry Schein Is Placed Ahead of Q3 Earnings5
22.10.Deep Dive Into Henry Schein Stock: Analyst Perspectives (8 Ratings)4
22.10.Henry Schein, Inc.: Henry Schein to Participate in Upcoming Investor Conferences in November326Henry Schein, Inc., (Nasdaq: HSIC) the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following...
► Artikel lesen
21.10.Earnings Preview: What to Expect From Henry Schein's Report4
16.10.Biomerica, Inc.: Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods IBS Test in the U.S.294- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributors- Relationship Marks a Key Milestone in Biomerica's Commercialization Strategy...
► Artikel lesen
25.09.Henry Schein Stock: Is HSIC Underperforming the Health Care Sector?7
23.09.What Analysts Are Saying About Henry Schein Stock4
23.09.Henry Schein Sees Steady Smile As Dental Market Growth Holds: Analyst4
Weiter >>
72 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1